Die meisten infizierten Menschen zeigen keine Symptome

Die Menschen sind zwar mit SARS-CoV-2 infiziert, aber nicht an COVID-19 erkrankt!

Symptome, die bei Erkrankten häufig beobachtet werden:

Häufigkeit laut WHO & RKI: 87,9%

trocken oder mit wenig Auswurf

Häufigkeit laut WHO & RKI: 67,7%

Häufigkeit laut WHO & RKI: 18,6%

Häufigkeit laut WHO & RKI: 14,8%

Häufigkeit laut WHO: 13,9%; laut RKI: ca. 15%
Liu Qing-quan: „Praktisch alle Patienten klagen über einen trockenen und schmerzenden Hals“

Häufigkeit laut WHO: 13,6%; laut RKI: ca. 15%

Häufigkeit laut WHO & RKI: 5,0%

Akkordeon Inhalt

Häufigkeit laut RKI: ca. 5%

Häufigkeit laut WHO & RKI: 3,7%

Häufigkeit laut WHO: 30-59%; laut RKI: „gelegentlich“;

„We also find that a combination of loss of smell and taste, fever, persistent cough, fatigue, diarrhoea, abdominal pain and loss of appetite is predictive of COVID-19 positive test with sensitivity 0.54[0.44; 0.63], specificity 0.86[0.80; 0.90], ROC-AUC 0.77[0.72; 0.82] in the test set, and cross-validation ROC-AUC 0.75[0.72; 0.77].“
[Quelle: https://www.medrxiv.org/content/10.1101/2020.04.05.20048421v1]

Häufigkeit laut WHO: nicht genannt; laut RKI: nicht genannt;

„We also find that a combination of loss of smell and taste, fever, persistent cough, fatigue, diarrhoea, abdominal pain and loss of appetite is predictive of COVID-19 positive test with sensitivity 0.54[0.44; 0.63], specificity 0.86[0.80; 0.90], ROC-AUC 0.77[0.72; 0.82] in the test set, and cross-validation ROC-AUC 0.75[0.72; 0.77].“
[Quelle: https://www.medrxiv.org/content/10.1101/2020.04.05.20048421v1]

Häufigkeit laut WHO: 4,8%; laut RKI: „gelegentlich“;

Häufigkeit laut WHO: 33,4%; laut RKI: nicht genannt;

Häufigkeit laut WHO: 11,4%; laut RKI: nicht genannt;

Häufigkeit laut WHO: 5,0%; laut RKI: nicht genannt;

Häufigkeit laut WHO: 0,9%; laut RKI: nicht genannt;

Häufigkeit laut WHO: 0,8%; laut RKI: nicht genannt;

Häufigkeit laut WHO: nicht genannt; laut RKI: nicht genannt; „We also find that a combination of loss of smell and taste, fever, persistent cough, fatigue, diarrhoea, abdominal pain and loss of appetite is predictive of COVID-19 positive test with sensitivity 0.54[0.44; 0.63], specificity 0.86[0.80; 0.90], ROC-AUC 0.77[0.72; 0.82] in the test set, and cross-validation ROC-AUC 0.75[0.72; 0.77].“ [Quelle: https://www.medrxiv.org/content/10.1101/2020.04.05.20048421v1]

68%

[DOI:https://doi.org/10.1016/S0140-6736(20)30183-5]

60%

DOI: https://doi.org/10.5114/ait.2020.93867

Online publish date: 2020/03/22
Mild to moderate hepatic injury, expressed by elevated transaminases, hypoproteinaemia, and prolonged prothrombin time, have been reported in clinical studies of COVID-19, but little is known about 2019-nCoV liver infection. In previous SARS studies, almost 60% of patients presented with liver problems. The presence of SARS genetic material in the liver tissue confirmed the direct infection of hepatocytes with coronavirus, with impaired hepatocyte function, without fibrin deposition or fibrosis [13]. It is believed that hepatotoxicity in the course of 2019-nCoV or SARS-CoV infection can be interpreted as viral hepatitis or a secondary effect linked with drug toxicity due to the high intake of antiviral drugs, antibiotics, and steroids, as well as excessive immune response. RNA sequencing data from single cells from two independent cohorts revealed a significant increase in ACE2 expression in cholangiocytes (59.7% of cells) instead of hepatocytes (2.6% of cells), suggesting that 2019-nCoV may lead to direct injury of intrahepatic bile ducts [14].
13. Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004; 39: 302-310. doi: 10.1002/hep.20111.
14. Chai XQ, Hu LF, Zhang Y, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. Preprint. 2020. bioRxiv 931766. doi: 10.1101/2020.02.03.931766.

20.4%

https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16387

dicker, schleimiger, weißer oder gelber Zungenbelag (Liu Qing-quan)

Quellen:

Comments are closed, but trackbacks and pingbacks are open.